Lipocine Inc.

LPCN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$6,206$4,772$3,148$2,951
Short-Term Investments$15,427$17,264$29,381$41,667
Receivables$120$52$660$247
Inventory$0$0$0$0
Other Curr. Assets$568$773$945$1,514
Total Curr. Assets$22,322$22,861$34,135$46,380
Property Plant & Equip (Net)$165$116$132$7
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$3,253$2,022
Tax Assets$0$0$0$0
Other NC Assets$24$24$24$4,074
Total NC Assets$189$140$3,408$6,103
Other Assets$0$0$0$0
Total Assets$22,511$23,001$37,543$52,482
Liabilities
Payables$272$1,396$600$1,289
Short-Term Debt$0$0$0$2,311
Tax Payable$0$0$0$0
Deferred Revenue$320$0$0$0
Other Curr. Liab.$921$1,236$1,078$2,016
Total Curr. Liab.$1,513$2,632$1,678$5,617
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$230$1,296
Total NC Liab.$0$0$230$1,296
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$1,513$2,632$1,908$6,912
Equity
Pref Stock$0$0$0$0
Common Stock$9$9$9$9
Retained Earnings-$199,769-$199,777-$183,425-$172,666
AOCI$9$7-$20-$18
Other Equity$220,748$220,131$219,071$218,246
Total Equity$20,998$20,369$35,635$45,570
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$22,511$23,001$37,543$52,482
Net Debt-$6,206-$4,772-$3,148-$640